Published in Clin Chest Med on April 08, 2013
HIV-associated obstructive lung diseases: insights and implications for the clinician. Lancet Respir Med (2014) 1.10
Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management. Semin Respir Crit Care Med (2015) 0.87
Pneumococcal vaccine and patients with pulmonary diseases. Am J Med (2014) 0.86
Screening for Cancer in Persons Living with HIV Infection. Trends Cancer (2016) 0.75
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med (1998) 53.26
Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med (2011) 38.61
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med (1995) 21.16
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (2007) 11.06
Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med (2008) 7.71
Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS (2006) 7.08
Association of cancer with AIDS-related immunosuppression in adults. JAMA (2001) 6.80
Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst (2005) 6.69
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet (2005) 6.60
Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer (2008) 6.13
Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr (2006) 5.87
Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69
Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol (2009) 4.38
Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis (2011) 4.31
Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med (2010) 4.30
Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol (2003) 4.15
A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr (2009) 3.76
HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis (2007) 3.56
Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis (2009) 3.52
Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS (2010) 2.98
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr (2012) 2.95
Inflammation in the development of lung cancer: epidemiological evidence. Expert Rev Anticancer Ther (2008) 2.83
Venous thromboembolism and cancer: risks and outcomes. Circulation (2003) 2.68
The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med (2005) 2.58
Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res (2005) 2.55
Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol (2006) 2.46
Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood (2001) 2.37
Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer (2006) 2.25
Elevated risk of lung cancer among people with AIDS. AIDS (2007) 2.20
Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res (2004) 2.17
HIV-related lung cancer in the era of highly active antiretroviral therapy. AIDS (2003) 2.15
Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study. Lancet Oncol (2012) 2.14
Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol (2005) 2.07
HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev (2011) 2.02
Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS (2002) 1.98
Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer (2009) 1.95
Kaposi's sarcoma causing pulmonary infiltrates and respiratory failure in the acquired immunodeficiency syndrome. Ann Intern Med (1985) 1.86
Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome. AIDS Patient Care STDS (2005) 1.84
Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection. Clin Infect Dis (2011) 1.82
The pulmonary manifestations of AIDS-related non-Hodgkin's lymphoma. Chest (1996) 1.77
Significance of abnormal chest radiograph findings in patients with HIV-1 infection without respiratory symptoms. Chest (2002) 1.72
The association between cigarette smoking and selected HIV-related medical conditions. AIDS (1996) 1.72
Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr (2005) 1.71
Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr (2006) 1.66
Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival. J Acquir Immune Defic Syndr (2002) 1.63
Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol (1992) 1.60
Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States. Cancer (2010) 1.54
HIV as an independent risk factor for incident lung cancer. AIDS (2012) 1.54
Risk of cancer in people with AIDS. AIDS (1999) 1.47
Thrombotic complications in patients infected with HIV in the era of highly active antiretroviral therapy: a case series. Clin Infect Dis (2004) 1.44
Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer (2007) 1.40
Cancer incidence in people with AIDS in Italy. Int J Cancer (2010) 1.39
HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data. Int J STD AIDS (1999) 1.38
The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma. Chest (2000) 1.37
HPV infections and lung cancer. J Clin Pathol (2002) 1.35
Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS (1998) 1.34
Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users. J Acquir Immune Defic Syndr (2010) 1.33
A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy. Lancet (2006) 1.32
Incidence of malignant neoplasms among HIV-infected persons in Scotland. Br J Cancer (2003) 1.32
Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion. J Natl Cancer Inst (2010) 1.31
Including persons with HIV infection in cancer clinical trials. J Clin Oncol (2008) 1.30
Use of antineoplastic agents in patients with cancer who have HIV/AIDS. Lancet Oncol (2011) 1.30
Is chronic HIV infection associated with venous thrombotic disease? A systematic review. Neth J Med (2005) 1.27
Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users. Addict Behav (2010) 1.27
Previous lung disease and lung cancer risk among women (United States). Cancer Causes Control (2000) 1.25
Pulmonary infections and risk of lung cancer among persons with AIDS. J Acquir Immune Defic Syndr (2010) 1.25
Cancer incidence in women with or at risk for HIV. Int J Cancer (2001) 1.23
Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS (2000) 1.23
Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects. JAMA (1998) 1.22
Association of venous thromboembolism with human immunodeficiency virus and mortality in veterans. Am J Med (2004) 1.19
The risk of cancer in HIV-infected people in southeast England: a cohort study. Br J Cancer (2005) 1.18
Lung cancer in HIV-infected patients in the era of highly active antiretroviral therapy. J Thorac Oncol (2007) 1.15
Venous thromboembolism in patients with HIV/AIDS: a case-control study. J Acquir Immune Defic Syndr (2008) 1.14
HIV infection in the etiology of lung cancer: confounding, causality, and consequences. Proc Am Thorac Soc (2011) 1.13
Lung cancer in HIV infected patients: facts, questions and challenges. Thorax (2006) 1.13
Presentation of AIDS-related pulmonary Kaposi's sarcoma diagnosed by bronchoscopy. Am J Respir Crit Care Med (1996) 1.13
Cancer incidence in AIDS patients in Catalonia, Spain. Eur J Cancer (2007) 1.11
HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV Study. J Clin Oncol (2010) 1.09
Pulmonary involvement in Kaposi sarcoma: correlation between imaging and pathology. Orphanet J Rare Dis (2009) 1.09
Chlamydia pneumoniae infection and risk for lung cancer. Cancer Epidemiol Biomarkers Prev (2010) 1.07
Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy. HIV Med (2006) 1.04
A fatal case of kaposi sarcoma due to immune reconstitution inflammatory syndrome. Am J Med Sci (2012) 1.04
AIDS-related bronchogenic carcinoma: fact or fiction? Chest (1998) 1.03
Non-acquired immunodeficiency syndrome-defining malignancies in patients infected with human immunodeficiency virus. Arch Pathol Lab Med (2003) 1.01
Results of chemotherapy in 30 AIDS patients with symptomatic pulmonary Kaposi's sarcoma. Thorax (1994) 1.00
High cancer-related mortality in an urban, predominantly African-American, HIV-infected population. AIDS (2013) 0.99
AIDS-related Kaposi sarcoma of the lung: radiographic findings and staging system with bronchoscopic correlation. Radiology (1995) 0.98
Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy. J Clin Oncol (2005) 0.97
Cigarette smoking: a modifier of human immunodeficiency virus type 1 infection? J Acquir Immune Defic Syndr (1991) 0.96
Lung cancer in patients with HIV Infection and review of the literature. Med Oncol (2004) 0.96
Human immunodeficiency virus-associated Kaposi sarcoma as an immune reconstitution inflammatory syndrome: a literature review and case report. J Periodontol (2008) 0.95
Prevalence and distribution of HHV-8 in different subpopulations, with and without HIV infection, in Spain. AIDS (2001) 0.95
Zidovudine-didanosine coexposure potentiates DNA incorporation of zidovudine and mutagenesis in human cells. Proc Natl Acad Sci U S A (2000) 0.93
Unexplained thrombosis in HIV-infected patients receiving protease inhibitors: report of seven cases. Am J Med (1999) 0.90
HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort study. HIV Med (2010) 0.90
Radiotherapy in the management of epidemic Kaposi's sarcoma: a retrospective study of 643 cases. Radiother Oncol (1998) 0.90
The viral etiology of AIDS-associated malignancies. Adv Pharmacol (2008) 0.89
Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature (2009) 13.99
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet (2007) 6.83
A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr (2009) 3.76
Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis (2010) 3.72
Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol (2007) 3.46
Influence of HLA-C expression level on HIV control. Science (2013) 3.27
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet (2009) 3.03
Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology (2008) 3.00
Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. J Acquir Immune Defic Syndr (2013) 2.78
Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. Am J Respir Crit Care Med (2008) 2.63
Limited uptake of hepatitis C treatment among injection drug users. J Community Health (2008) 2.61
Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis (2012) 2.50
HIV incidence determination in the United States: a multiassay approach. J Infect Dis (2012) 2.47
High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda. Antivir Ther (2011) 2.20
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med (2012) 2.18
Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay. AIDS (2014) 2.18
An oversized allograft is associated with improved survival after lung transplantation for idiopathic pulmonary arterial hypertension. J Heart Lung Transplant (2013) 2.13
Neighborhood poverty and injection cessation in a sample of injection drug users. Am J Epidemiol (2010) 2.07
KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog (2006) 2.06
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis (2009) 2.05
Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis (2013) 1.94
The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohort. AIDS (2013) 1.92
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med (2015) 1.86
Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med (2013) 1.82
Changes in blood-borne infection risk among injection drug users. J Infect Dis (2011) 1.74
APOBEC3B deletion and risk of HIV-1 acquisition. J Infect Dis (2009) 1.74
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr (2013) 1.72
Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA (2010) 1.69
Impact of the lung allocation score on resource utilization after lung transplantation in the United States. J Heart Lung Transplant (2010) 1.67
Progression of liver fibrosis among injection drug users with chronic hepatitis C. Hepatology (2006) 1.63
Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection. Virology (2006) 1.59
Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users. J Infect Dis (2010) 1.58
Lung size mismatch and survival after single and bilateral lung transplantation. Ann Thorac Surg (2013) 1.54
Activation-induced cell death drives profound lung CD4(+) T-cell depletion in HIV-associated chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.50
An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope (2010) 1.49
Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users. AIDS (2013) 1.49
IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection. J Infect Dis (2010) 1.48
Frailty, HIV infection, and mortality in an aging cohort of injection drug users. PLoS One (2013) 1.46
The relationship of physical performance with HIV disease and mortality. AIDS (2014) 1.46
The effect of neighborhood deprivation and residential relocation on long-term injection cessation among injection drug users (IDUs) in Baltimore, Maryland. Addiction (2011) 1.46
20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.44
Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers. J Int AIDS Soc (2012) 1.44
Lung transplantation in older patients with cystic fibrosis: analysis of UNOS data. J Heart Lung Transplant (2009) 1.43
Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users. AIDS (2012) 1.41
Discordance between CD4+ T-lymphocyte counts and percentages in HIV-infected persons with liver fibrosis. Clin Infect Dis (2012) 1.41
Respiratory epithelial gene expression in patients with mild and severe cystic fibrosis lung disease. Am J Respir Cell Mol Biol (2006) 1.39
NPHS2 variation in sporadic focal segmental glomerulosclerosis. J Am Soc Nephrol (2007) 1.36
Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection. Am J Epidemiol (2005) 1.34
Nonstructured treatment interruptions among injection drug users in Baltimore, MD. J Acquir Immune Defic Syndr (2009) 1.34
Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. J Infect Dis (2010) 1.33
Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users. J Acquir Immune Defic Syndr (2010) 1.33
Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls. PLoS Pathog (2013) 1.33
Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. Clin Infect Dis (2011) 1.29
Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus. J Infect Dis (2010) 1.28
HIV infection, immune suppression, and uncontrolled viremia are associated with increased multimorbidity among aging injection drug users. Clin Infect Dis (2011) 1.28
Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users. Addict Behav (2010) 1.27
High frequency of false-positive hepatitis C virus enzyme-linked immunosorbent assay in Rakai, Uganda. Clin Infect Dis (2013) 1.26
A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. J Virol (2012) 1.24
Polymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals. PLoS Genet (2007) 1.23
Survival after single versus bilateral lung transplantation for high-risk patients with pulmonary fibrosis. Ann Thorac Surg (2009) 1.22
Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa. Environ Health Perspect (2008) 1.22
The impact of center volume on survival in lung transplantation: an analysis of more than 10,000 cases. Ann Thorac Surg (2009) 1.20
Correlates of non-medical prescription drug use among a cohort of injection drug users in Baltimore City. Addict Behav (2011) 1.20
Mannose binding lectin genotypes influence recovery from hepatitis B virus infection. J Virol (2005) 1.19
Effect of cigarette smoking on HIV acquisition, progression, and mortality. AIDS Educ Prev (2009) 1.17
Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV Type 1 transmission and AIDS disease progression. Am J Hum Genet (2006) 1.17
Association of operative time of day with outcomes after thoracic organ transplant. JAMA (2011) 1.16
Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax (2011) 1.16
The effect of lung size mismatch on complications and resource utilization after bilateral lung transplantation. J Heart Lung Transplant (2012) 1.15
Genome-wide association study implicates PARD3B-based AIDS restriction. J Infect Dis (2011) 1.15
Lung allocation score predicts survival in lung transplantation patients with pulmonary fibrosis. Ann Thorac Surg (2009) 1.13
HIV infection in the etiology of lung cancer: confounding, causality, and consequences. Proc Am Thorac Soc (2011) 1.13
CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation? AIDS Res Ther (2010) 1.13
The impact of recipient body mass index on survival after lung transplantation. J Heart Lung Transplant (2010) 1.13
Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. J Infect Dis (2011) 1.11
Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection. J Clin Virol (2007) 1.10
Donor-recipient size matching and survival after lung transplantation. A cohort study. Ann Am Thorac Soc (2013) 1.09
Trajectories of injection drug use over 20 years (1988-2008) in Baltimore, Maryland. Am J Epidemiol (2011) 1.09
Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDS. PLoS Pathog (2007) 1.08
HIV infection is associated with reduced pulmonary diffusing capacity. J Acquir Immune Defic Syndr (2013) 1.07
Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV. BMC Pulm Med (2010) 1.06
Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in The Gambia. Liver Int (2010) 1.05
HIV-associated lung infections and complications in the era of combination antiretroviral therapy. Proc Am Thorac Soc (2011) 1.05
Insurance status is an independent predictor of long-term survival after lung transplantation in the United States. J Heart Lung Transplant (2011) 1.04
Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance. J Infect Dis (2008) 1.03
The longitudinal association between homelessness, injection drug use, and injection-related risk behavior among persons with a history of injection drug use in Baltimore, MD. Drug Alcohol Depend (2013) 1.03
KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection. PLoS Pathog (2011) 1.02
Improving survival among HIV-infected injection drug users: how should we define success? Clin Infect Dis (2007) 1.02
Correlates of elevated interleukin-6 and C-reactive protein in persons with or at high risk for HCV and HIV infections. J Acquir Immune Defic Syndr (2013) 1.02
Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan. Hepatology (2011) 1.00
Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. PLoS One (2010) 1.00
Ser-249TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia, West Africa. Int J Cancer (2004) 0.98
Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996-2008. Clin Infect Dis (2010) 0.98